Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0002 Transporter Info | ||||
| Gene Name | ABCC2 | ||||
| Transporter Name | Multidrug resistance-associated protein 2 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Glutathione Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 124886 | ||||
| Docking Score | -7.108 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C10H17N3O6S | ||||
| Molecular Weight | 307.33 | ||||
| Canonical SMILES |
C(CC(=O)N[C@@H](CS)C(=O)NCC(=O)O)[C@@H](C(=O)O)N
|
||||
| InChI |
InChI=1S/C10H17N3O6S/c11-5(10(18)19)1-2-7(14)13-6(4-20)9(17)12-3-8(15)16/h5-6,20H,1-4,11H2,(H,12,17)(H,13,14)(H,15,16)(H,18,19)/t5-,6-/m0/s1
|
||||
| InChIKey | RWSXRVCMGQZWBV-WDSKDSINSA-N | ||||
| Pharmaceutical Properties | Xlogp | -4.5 | Rotatable Bond Count | 9 | |
| Hydrogen Bond Donor Count | 6 | Hydrogen Bond Acceptor Count | 8 | ||
| Xenobiotic Name | Canagliflozin Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 24812758 | ||||
| Docking Score | -6.966 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C24H25FO5S | ||||
| Molecular Weight | 444.5 | ||||
| Canonical SMILES |
CC1=C(C=C(C=C1)[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F
|
||||
| InChI |
InChI=1S/C24H25FO5S/c1-13-2-3-15(24-23(29)22(28)21(27)19(12-26)30-24)10-16(13)11-18-8-9-20(31-18)14-4-6-17(25)7-5-14/h2-10,19,21-24,26-29H,11-12H2,1H3/t19-,21-,22+,23-,24+/m1/s1
|
||||
| InChIKey | XTNGUQKDFGDXSJ-ZXGKGEBGSA-N | ||||
| Pharmaceutical Properties | Xlogp | 3.2 | Rotatable Bond Count | 5 | |
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 7 | ||
| Xenobiotic Name | Emtricitabine Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 60877 | ||||
| Docking Score | -6.939 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C8H10FN3O3S | ||||
| Molecular Weight | 247.25 | ||||
| Canonical SMILES |
C1[C@H](O[C@H](S1)CO)N2C=C(C(=NC2=O)N)F
|
||||
| InChI |
InChI=1S/C8H10FN3O3S/c9-4-1-12(8(14)11-7(4)10)5-3-16-6(2-13)15-5/h1,5-6,13H,2-3H2,(H2,10,11,14)/t5-,6+/m0/s1
|
||||
| InChIKey | XQSPYNMVSIKCOC-NTSWFWBYSA-N | ||||
| Pharmaceutical Properties | Xlogp | -0.6 | Rotatable Bond Count | 2 | |
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 5 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.